These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 14367147)

  • 21. A study of the posthypnotic effects of cycloheptenylethyl barbituric acid (Medomin) in man.
    AINLEY AB
    N Y State J Med; 1957 May; 57(9):1599-603. PubMed ID: 13430911
    [No Abstract]   [Full Text] [Related]  

  • 22. Subacute oral toxicity of cycloheptenylethyl barbituric acid (medomin) in rats and dogs.
    KUNDZINS W; PAYNTER OE; TUSING TW
    Arch Int Pharmacodyn Ther; 1956 Aug; 107(2):133-7. PubMed ID: 13355485
    [No Abstract]   [Full Text] [Related]  

  • 23. [Metabolism of phanodorm].
    GOLDSCHMIDT S; KOSS FW
    Z Naturforsch B; 1959 Jan; 14B(1):68-9. PubMed ID: 13648640
    [No Abstract]   [Full Text] [Related]  

  • 24. General pharmacology of barbiturates. Duration of action, metabolism, physicochemical factors.
    Doenicke A
    Acta Anaesthesiol Scand Suppl; 1965; 17():11-6. PubMed ID: 5866689
    [No Abstract]   [Full Text] [Related]  

  • 25. [Distribution, metabolic elimination and narcotic efficacy of the optical antipodes of methylphenobarbital].
    Büch H; Rummel W; Buzello W; Neurohr O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):99-101. PubMed ID: 4239260
    [No Abstract]   [Full Text] [Related]  

  • 26. Placental transmission of sodium barbital.
    FLOWERS CE
    Obstet Gynecol; 1957 Mar; 9(3):332-5. PubMed ID: 13419244
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacokinetics of some homologous series of barbiturates in the intact rat and in the isolated perfused rat liver.
    Yih TD; van Rossum JM
    J Pharmacol Exp Ther; 1977 Oct; 203(1):184-92. PubMed ID: 909052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of insulin upon plasma pentothal sodium levels; preliminary report.
    EDER WP; McCAMPBELL MD
    Surg Forum; 1953; (38th Congress):366-72. PubMed ID: 13122464
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic use of soporifics in psychiatric-neurologic diseases; experience with medomin].
    LAIBLE E
    Wien Med Wochenschr; 1954 Oct; 104(44):886-7. PubMed ID: 14348895
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rectal absorption of neurotropic drugs; reactional absorption of luminal sodium and the antagonism between strychnine administered subcutaneously and luminal sodium administered rectally].
    SERRA A
    Arch Farmacol Sper Sci Affin; 1953; 81(3-4):69-76. PubMed ID: 13181584
    [No Abstract]   [Full Text] [Related]  

  • 31. Biotransformation of N-methylcyclobarbital in vivo in rabbit and rat.
    Miyano K; Shimodouzono Y; Toki S
    Xenobiotica; 1985 May; 15(5):381-9. PubMed ID: 2863899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Distribution and metabolism of ethanol and barbiturates in the body during their combined use (a review of the literature)].
    Sergeev PV; Chernobrovkina TV
    Farmakol Toksikol; 1975; 38(6):737-46. PubMed ID: 776658
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of alpha- or beta-cyclodextrin on gastrointestinal absorption of barbituric acid derivatives (author's transl)].
    Koizumi K; Kidera Y
    Yakugaku Zasshi; 1977 Jul; 97(7):705-11. PubMed ID: 915696
    [No Abstract]   [Full Text] [Related]  

  • 34. The metabolism of butabarbital (butisol) in the dog.
    MAYNERT EW; LOSIN L
    J Pharmacol Exp Ther; 1955 Nov; 115(3):275-82. PubMed ID: 13272177
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the pharmacology of 5-ethyl-5(3-hydroxyisoamyl)-barbituric acid--a breakdown product of 5-ethyl-5-isoamyl-barbituric acid].
    Irrgang K
    Arzneimittelforschung; 1965 Jun; 15(6):688-91. PubMed ID: 5899249
    [No Abstract]   [Full Text] [Related]  

  • 36. Radioimmunoassay for hepatic N-demethylation of metharbital in vitro.
    Flynn EJ; Spector S
    J Pharmacol Exp Ther; 1974 May; 189(2):550-6. PubMed ID: 4829231
    [No Abstract]   [Full Text] [Related]  

  • 37. [Metabolism of 5-methyl-5-phenyl-barbituric acid].
    LEDVINA M; KACL K; MRAZ M; DOLEZAL V
    Cas Lek Cesk; 1959 Jul; 98(27):840-2. PubMed ID: 13671481
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on metabolism of some short-acting intravenous narcotics].
    FREY HH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1957; 232(1):333-5. PubMed ID: 13526884
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of dimercaprol on the metabolism of pentobarbital in mice.
    KAHN JB
    J Pharmacol Exp Ther; 1953 Nov; 109(3):292-300. PubMed ID: 13109689
    [No Abstract]   [Full Text] [Related]  

  • 40. [Metabolism of 5-vinyl-5-(1'-methylbutyl)-barbituric acid (vinylbital) in man. 3. Metabolism and excretion of (-)-vinylbital].
    Geldmacher-von Mallinck ; Egger B
    Arzneimittelforschung; 1971 Aug; 21(8):1272-4. PubMed ID: 5110033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.